Moderna stock at USD 198.19 on September 28, 2026
Published on 09/28/2026 at 19:51 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Moderna Inc. stock last traded at USD 198.19 on the Nasdaq on September 28, 2026, at 5:50:41 p.m. UTC. The share price was down 0.34 percent, or USD 0.69, from the previous close.
Trading session
The quote was recorded during the regular trading session. Moderna's primary listing is Nasdaq under the ticker MRNA.
Moderna outlines ESMO presentations
In a September 21, 2026 release, Moderna announced that three abstracts on intismeran autogene, its investigational mRNA-based individualized neoantigen therapy, had been accepted for presentation at the European Society for Medical Oncology Congress 2026. The company said the event will take place October 23-27 in Madrid, with Phase 3 melanoma data scheduled for a Presidential Symposium. Moderna's press release also said the company plans to host an investor webcast on October 24.
Oncology research focus
In a September 24 article authored by Chief Development Officer David Berman, Moderna described its work with Merck on an investigational individualized neoantigen therapy and discussed research into earlier cancer intervention, including an mRNA-based approach being studied in Lynch syndrome. Moderna's article said the Lynch syndrome research remains early-stage.
